Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New platinum compound licensed by NeoOncoRx, heading for phase III

Sep. 13, 2001

Progenics and Cytogen team up with AlphaVax to develop PSMA ArV vaccine

Sep. 13, 2001

Novuspharma antitumor agents particularly effective against solid tumors

Sep. 12, 2001

Targeted apoptosis research program at Antisoma expanded by newly acquired rights from NIH

Sep. 12, 2001

FDA panel emits positive recommendation for Zevalin

Sep. 12, 2001

Clinical trial of Cur-61414 commences for treatment of sporadic BCC

Sep. 12, 2001

Joint Onco TCS clinical development program expanded

Sep. 12, 2001

WHI-P131: a dual-acting antileukemic, anti-GVHD compound targeting JAK3

Sep. 10, 2001

HGS initiates new clinical trial with repifermin for treatment of mucositis

Sep. 10, 2001

Simplified salicylihalimide analogues which retain antitumor activity

Sep. 10, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...